𝔖 Bobbio Scriptorium

✦ LIBER ✦

Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status

✍ Scribed by C.S. Thomson; C.J. Twelves; E.A. Mallon; R.E. Leake

Book ID: 114482873
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 174 KB
Volume: 11
Category: Article
ISSN: 0960-9776
DOI: 10.1054/brst.2002.0451

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of adjuvant endocrine treatme

Comparison of adjuvant endocrine treatment (tamoxifen and goserelin) vs. chemotherapy (CMF) in premenopausal patients with hormone-responsive early breast cancer: Results from the Austrian Breast Cancer Study Group (ABCSG)

✍ E. Kubista; M. Seifert; M. Gnant; R. Jakesz 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Comparison of adjuvant therapy with tamo

Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5

✍ R. Jakesz; H. Hausmaninger; H. Samonigg; E. Kubista; D. Depisch; M. Fridrik; M. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 118 KB